162 related articles for article (PubMed ID: 2862851)
21. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
Raffa RB; Friderichs E; Reimann W; Shank RP; Codd EE; Vaught JL
J Pharmacol Exp Ther; 1992 Jan; 260(1):275-85. PubMed ID: 1309873
[TBL] [Abstract][Full Text] [Related]
22. Alpha adrenoceptor subtypes involved in the emetic action in dogs.
Hikasa Y; Ogasawara S; Takase K
J Pharmacol Exp Ther; 1992 May; 261(2):746-54. PubMed ID: 1349647
[TBL] [Abstract][Full Text] [Related]
23. Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
Ocaña M; Barrios M; Baeyens JM
J Pharmacol Exp Ther; 1996 Mar; 276(3):1136-42. PubMed ID: 8786544
[TBL] [Abstract][Full Text] [Related]
24. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.
Gulati A; Bhalla S; Matwyshyn G; Zhang Z; Andurkar SV
Pharmacology; 2009; 83(1):45-58. PubMed ID: 19052482
[TBL] [Abstract][Full Text] [Related]
25. Comparison of alpha-adrenoceptor involvement in the antinociceptive action of tizanidine and clonidine in the mouse.
Kameyama T; Nabeshima T; Matsuno K; Sugimoto A
Eur J Pharmacol; 1986 Jun; 125(2):257-64. PubMed ID: 2874991
[TBL] [Abstract][Full Text] [Related]
26. A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions.
Fielding S; Wilker J; Hynes M; Szewczak M; Novick WJ; Lal H
J Pharmacol Exp Ther; 1978 Dec; 207(3):899-905. PubMed ID: 569695
[TBL] [Abstract][Full Text] [Related]
27. Receptor mechanisms for 5-hydroxytryptamine in isolated human umbilical artery and vein.
Tuncer M; Doğan N; Oktay S; Kayaalp SO
Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):17-27. PubMed ID: 2864904
[TBL] [Abstract][Full Text] [Related]
28. Clonidine and guanfacine-induced antinociception in visceral pain: possible role of alpha 2/I2 binding sites.
Sabetkasaie M; Vala S; Khansefid N; Hosseini AR; Sadat Ladgevardi MA
Eur J Pharmacol; 2004 Oct; 501(1-3):95-101. PubMed ID: 15464067
[TBL] [Abstract][Full Text] [Related]
29. Sleeping times evoked by alpha adrenoceptor agonists in two-day-old chicks: an experimental model to evaluate full and partial agonists at central alpha-2 adrenoceptors.
Roach AG; Doxey JC; Strachan DA; Cavero I
J Pharmacol Exp Ther; 1983 Nov; 227(2):421-8. PubMed ID: 6138427
[TBL] [Abstract][Full Text] [Related]
30. [The potential antinarcotic effects of guanfacine].
Marusov IV; Bogdanov EG; Marusova IB
Eksp Klin Farmakol; 1996; 59(3):24-7. PubMed ID: 8974578
[TBL] [Abstract][Full Text] [Related]
31. Antinociceptive effect of the GABAmimetic 4,5,6,7-tetrahydroisoxazolo [5, 4-c]pyridin-3-ol (THIP): chronic treatment increases alpha-2 adrenoceptors in the mouse brain.
Costa LG; Murphy SD
J Pharmacol Exp Ther; 1984 May; 229(2):386-90. PubMed ID: 6325663
[TBL] [Abstract][Full Text] [Related]
32. Substance P-induced long-term blockade of spinal adrenergic analgesia: reversal by morphine and naloxone.
Nance PW; Sawynok J
J Pharmacol Exp Ther; 1987 Mar; 240(3):972-7. PubMed ID: 2435888
[TBL] [Abstract][Full Text] [Related]
33. Studies on the antinociceptive action of alpha-agonist drugs and their interactions with opioid mechanisms.
Bentley GA; Newton SH; Starr J
Br J Pharmacol; 1983 May; 79(1):125-34. PubMed ID: 6135474
[TBL] [Abstract][Full Text] [Related]
34. Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance.
Monasky MS; Zinsmeister AR; Stevens CW; Yaksh TL
J Pharmacol Exp Ther; 1990 Aug; 254(2):383-92. PubMed ID: 1974633
[TBL] [Abstract][Full Text] [Related]
35. N-acetyl beta-endorphin-(1-31) and substance P regulate the supraspinal antinociception mediated by mu opioid and alpha-2 adrenoceptors but not by delta opioid receptors in the mouse.
Sánchez-Blázquez P; Garzón J
J Pharmacol Exp Ther; 1993 May; 265(2):835-43. PubMed ID: 7684446
[TBL] [Abstract][Full Text] [Related]
36. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates.
Ossipov MH; Harris S; Lloyd P; Messineo E
J Pharmacol Exp Ther; 1990 Dec; 255(3):1107-16. PubMed ID: 2262895
[TBL] [Abstract][Full Text] [Related]
37. Role of alpha-2 adrenergic receptors in the control of diarrhea and intestinal motility.
Doherty NS; Hancock AA
J Pharmacol Exp Ther; 1983 May; 225(2):269-74. PubMed ID: 6132991
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
Solomon RE; Brody MJ; Gebhart GF
J Pharmacol Exp Ther; 1989 Oct; 251(1):27-38. PubMed ID: 2571720
[TBL] [Abstract][Full Text] [Related]
39. A comparison of muscarinic cholinergic involvement in the antinociceptive effects of morphine and clonidine in the mouse.
Lipman JJ; Spencer PS
Eur J Pharmacol; 1980 Jun; 64(4):249-58. PubMed ID: 7389822
[TBL] [Abstract][Full Text] [Related]
40. Effect of antisense knock-down of alpha(2a)- and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat.
Wang XM; Zhang ZJ; Bains R; Mokha SS
Pain; 2002 Jul; 98(1-2):27-35. PubMed ID: 12098614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
